Cargando…
Ki-67 Evaluation for Clinical Decision in Metastatic Lung Carcinoids: A Proof of Concept
Accrual of metastatic pulmonary carcinoid patients for therapy is usually relied on clinical and histologic characterization, with no role for the proliferation activity as defined by Ki-67 labelling index (LI). A total of 14 carcinoid patients with tumour primaries (TP) and 19 corresponding tumour...
Autores principales: | Pelosi, Giuseppe, Massa, Federica, Gatti, Gaia, Righi, Luisella, Volante, Marco, Birocco, Nadia, Maisonneuve, Patrick, Sonzogni, Angelica, Harari, Sergio, Albini, Adriana, Papotti, Mauro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477754/ https://www.ncbi.nlm.nih.gov/pubmed/31041430 http://dx.doi.org/10.1177/2632010X19829259 |
Ejemplares similares
-
Distinctive pathological and clinical features of lung carcinoids with high proliferation index
por: Marchiò, Caterina, et al.
Publicado: (2017) -
Lung carcinoid tumours: histology and Ki‐67, the eternal rivalry
por: Centonze, Giovanni, et al.
Publicado: (2022) -
Partitioning of Bronchopulmonary Carcinoids in Two Different Prognostic Categories by Ki-67 Score
por: Grimaldi, Franco, et al.
Publicado: (2011) -
Pulmonary neuroendocrine carcinoid tumors: Is there a predictive role to the Ki 67 index?
por: Patané, Ana Karina, et al.
Publicado: (2021) -
High miR-100 expression is associated with aggressive features and modulates TORC1 complex activation in lung carcinoids
por: Rapa, Ida, et al.
Publicado: (2018)